Maximilian Kopp

Statistics

Publications

Citations

489

H-Index

Active since

1989

Affiliations

University Medical Center of the Johannes Gutenberg University Mainz(Current)

Johannes Gutenberg University Mainz

Boehringer Ingelheim (Germany)

Maximilian Kopp is an author at University Medical Center of the Johannes Gutenberg University Mainz specializing in pharmacology, medicine, and endothelial dysfunction.

Publications per year

1989–2017

Publications

The SGLT2 inhibitor empagliflozin improves the primary diabetic complications in ZDF rats

Sebastian Steven, Matthias Oelze, Alina Hanf et al. · Redox Biology · 2017 · 305 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Glucagon‐like peptide‐1 receptor signalling reduces microvascular thrombosis, nitro‐oxidative stress and platelet activation in endotoxaemic mice

Sebastian Steven, Kerstin Jurk, Maximilian Kopp et al. · British Journal of Pharmacology · 2016 · 101 citations · Full text

Medicine, Immunology, Pharmacology +17

Carbonic anhydrase activity in the peripheral nervous system of rat: the enzyme as a marker for muscle afferents

Matthias Szabolcs, Maximilian Kopp, Gabriele E. Schaden · Brain Research · 1989 · 51 citations

Life Sciences, Neurobiology, Neuroscience +11

Effect of soluble guanylyl cyclase activator and stimulator therapy on nitroglycerin-induced nitrate tolerance in rats

Alexander Jabs, Matthias Oelze, Yuliya Mikhed et al. · Vascular Pharmacology · 2015 · 32 citations

Medicine, Pharmacology, Biochemical Pharmacology +9

1–4 of 4